Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice

Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered

(2016) Yu Qi Qiao et al.   Journal of Digestive Diseases

Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells

(2016) Bianca Mendes Souza et al.   Microbial Cell Factories

Microcins mediate competition among Enterobacteriaceae in the inflamed gut

(2016) Martina Sassone-Corsi et al.   NATURE

Role and mechanisms of action ofEscherichia coliNissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

(2016) Franco Scaldaferri et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Outer Membrane Vesicles and Soluble Factors Released by Probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells

(2016) Carina-Shianya Alvarez et al.   Frontiers in Microbiology

Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains

(2016) María José Fábrega et al.   Frontiers in Microbiology

Outer Membrane Vesicles from the Probiotic Escherichia coli Nissle 1917 and the Commensal ECOR12 Enter Intestinal Epithelial Cells via Clathrin-Dependent Endocytosis and Elicit Differential Effects on DNA Damage

(2016) María-Alexandra Cañas et al.   PLoS One

The anti-inflammatory effect and potential mechanism of cardamonin in DSS-induced colitis

(2015) Gaiyan Ren et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis

(2015) Prashant Nighot et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model

(2015) Rebeca Martín et al.   BMC MICROBIOLOGY

The Intestinal Microbiota in Inflammatory Bowel Disease

(2015) Christoph Becker et al.   ILAR JOURNAL

Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease

(2015) Andrzej Wasilewski et al.   INFLAMMATORY BOWEL DISEASES

Escherichia coli Nissle 1917 in ulcerative colitis treatment: systematic review and meta-analysis

(2015)   Journal of Gastrointestinal and Liver Diseases

Pea (Pisum sativumL.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis

(2015) Mᵃ Pilar Utrilla et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Allicin Alleviates Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in BALB/c Mice

(2015) Ashok Kumar Pandurangan et al.   Oxidative Medicine and Cellular Longevity

A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii

(2015) José Garrido-Mesa et al.   PHARMACOLOGICAL RESEARCH

Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats

(2015) Altug Senol   WORLD JOURNAL OF GASTROENTEROLOGY

Animal models to study acute and chronic intestinal inflammation in mammals

(2015) Janelle A. Jiminez et al.   Gut Pathogens

Outer membrane vesicles – offensive weapons or good Samaritans?

(2015) Ingar Olsen et al.   Journal of Oral Microbiology

Inflammatory Bowel Disease: Etiology, Pathogenesis and Current Therapy

(2014) Joshua Ko et al.   CURRENT PHARMACEUTICAL DESIGN

Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats

(2014) Julio Galvez et al.   International Journal of Nanomedicine

Intestinal anti-inflammatory activity of the Serpylli herba extract in experimental models of rodent colitis

(2014) Francesca Algieri et al.   Journal of Crohns & Colitis

Glutamine Supplementation Attenuates Expressions of Adhesion Molecules and Chemokine Receptors on T Cells in a Murine Model of Acute Colitis

(2014) Yu-Chen Hou et al.   MEDIATORS OF INFLAMMATION

Inflammatory bowel disease: Pathogenesis

(2014) Yi-Zhen Zhang   WORLD JOURNAL OF GASTROENTEROLOGY

Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease

(2014) Xiao-Rong Xu   WORLD JOURNAL OF GASTROENTEROLOGY

The protective effect of trefoil factor 3 on the intestinal tight junction barrier is mediated by toll-like receptor 2 via a PI3K/Akt dependent mechanism

(2013) Nan Lin et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signaling in HT-29/B6 cells

(2013) N A Hering et al.   Mucosal Immunology

Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced Colitis

(2013) Chil-sung Kang et al.   PLoS One

Proteomic analysis of outer membrane vesicles from the probiotic strainEscherichia coliNissle 1917

(2013) Laura Aguilera et al.   PROTEOMICS

Regulatory Function of Trefoil peptides (TFF) on Intestinal Cell Junctional Complexes

(2012) Andrea Buda et al.   CELL COMMUNICATION AND ADHESION

Outer Membrane Vesicles of a Human Commensal Mediate Immune Regulation and Disease Protection

(2012) Yue Shen et al.   Cell Host & Microbe

Mucosal healing in inflammatory bowel diseases: a systematic review

(2012) Markus F Neurath et al.   GUT

The gut microbiota in IBD

(2012) Chaysavanh Manichanh et al.   Nature Reviews Gastroenterology & Hepatology

The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice

(2011) Natividad Garrido-Mesa et al.   BIOCHEMICAL PHARMACOLOGY

The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis

(2011) D Camuesco et al.   BRITISH JOURNAL OF PHARMACOLOGY

Recommendations for Probiotic Use—2011 Update

(2011) Martin H. Floch et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Lessons from probiotic-host interaction studies in murine models of experimental colitis

(2011) Ingmar J. J. Claes et al.   MOLECULAR NUTRITION & FOOD RESEARCH

The colonic microflora and probiotic therapy in health and disease

(2010) Fergus Shanahan   CURRENT OPINION IN GASTROENTEROLOGY

Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host

(2010) K. Gronbach et al.   INFECTION AND IMMUNITY

Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917

(2010) Ilja Trebichavsky et al.   NUTRITION REVIEWS

Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis

(2009) Pallavi Garg et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

A probiotic strain ofEscherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice

(2009) B Arribas et al.   BRITISH JOURNAL OF PHARMACOLOGY

Colitis-Associated Variant of TLR2 Causes Impaired Mucosal Repair Because of TFF3 Deficiency

(2009) Daniel K. Podolsky et al.   GASTROENTEROLOGY

The role of COX-2 in intestinal inflammation and colorectal cancer

(2009) D Wang et al.   ONCOGENE

Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function

(2008) Julia B. Ewaschuk et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The probiotic Escherichia coli strain Nissle 1917 induces γδ T cell apoptosis via caspase- and FasL-dependent pathways

(2008) Claudia Guzy et al.   INTERNATIONAL IMMUNOLOGY

Gut microbiota: a potential new territory for drug targeting

(2008) Wei Jia et al.   NATURE REVIEWS DRUG DISCOVERY

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA